Incidence of diabetes mellitus and neoplasia in Japanese short-statured children treated with growth hormone in the Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS)-Reference-Cited by-同舟云学术

Incidence of diabetes mellitus and neoplasia in Japanese short-statured children treated with growth hormone in the Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS)

Published:2017 Issue:4 Volume:26 Page:229-241
ISSN:0918-5739
Container-title:Clinical Pediatric Endocrinology
language:en
Short-container-title:Clin Pediatr Endocrinol

Author:

Yokoya Susumu¹,Hasegawa Tomonobu²,Ozono Keiichi³,Tanaka Hiroyuki⁴,Kanzaki Susumu⁵,Tanaka Toshiaki⁶,Chihara Kazuo⁷,Jia Nan⁸,Child Christopher J.⁹,Ihara Katsuichiro¹⁰,Funai Jumpei¹¹,Iwamoto Noriyuki¹⁰,Seino Yoshiki¹²

Affiliation:

1. Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan

2. Department of Pediatrics, School of Medicine, Keio University, Tokyo, Japan

3. Department of Pediatrics, Graduate School of Medicine, Osaka University, Osaka, Japan

4. Department of Pediatrics, Okayama Saiseikai General Hospital, Okayama, Japan

5. Division of Pediatrics and Perinatology, Tottori University Faculty of Medicine, Tottori, Japan

6. Tanaka Growth Clinic, Tokyo, Japan

7. Hyogo Prefectural Kakogawa Medical Center, Kakogawa, Japan

8. Lilly Research Laboratories, Eli Lilly and Company, Indiana, USA

9. Lilly Research Laboratories, Eli Lilly and Company, Windlesham, UK

10. Medical Science, Eli Lilly Japan K.K., Kobe, Japan

11. Scientific Communications, Eli Lilly Japan K.K., Kobe, Japan

12. JCHO Osaka Hospital, Osaka, Japan

Publisher

Japanese Society for Pediatric Endocrinology

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health

Link

https://www.jstage.jst.go.jp/article/cpe/26/4/26_2017-0012/_pdf

Reference39 articles.

1. 1. Tanaka, T. Growth hormone treatment in Japan: past, present, and future. Pediatr Endocrinol Rev 2012;10 (Suppl 1): 89–97.

2. 2. Child, CJ, Zimmermann, AG, Jia, N, Robison, LL, Brämswig, JH, Blum, WF. Assessment of primary cancer incidence in growth hormone-treated children: comparison of a multinational prospective observational study with population databases. Horm Res Paediatr 2016;85: 198–206.

3. 3. Cappa, M, Iughetti, L, Loche, S, Maghnie, M, Vottero, A, GeNeSIS National Board on behalf of the GeNeSIS Italian Investigators. Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study. J Endocrinol Invest 2016;39: 667–77.

4. 4. Luzuriaga Tomás, C, Oyarzabal Irigoyen, M, Caveda Cepas, E, Vázquez Salvi, LA, García-Pérez, LE, el grupo de investigadores españoles del estudio GeNeSIS. Safety and efficacy of growth hormone treatment: GeNeSIS study in Spain. An Pediatr (Barc) 2016;84: 139–47 (in Spanish).

5. 5. Nørrelund, H, Vahl, N, Juul, A, Møller, N, Alberti, KG, Skakkebaek, NE, et al. Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism. J Clin Endocrinol Metab 2000;85: 1912–7.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of Growth Hormone Replacement Therapy in Childhood-Onset Craniopharyngioma: A Systematic Review and Cohort Study;Neuroendocrinology;2023-05-25

2. EVALUATION OF GLUCOSE METABOLISM IN CHILDREN WITH GROWTH HORMONE DEFICIENCY DURING LONG-TERM GROWTH HORMONE TREATMENT;J PHYSIOL PHARMACOL;2018

3. Responses to the Letter to the Editor “Does growth-hormone treatment affect patients with and without a mitochondrial disorder differentially ?” (Vol. 27, No. 2, p. 107–108, 2018);Clinical Pediatric Endocrinology;2018

4. Does growth-hormone treatment affect patients with and without a mitochondrial disorder differentially?;Clinical Pediatric Endocrinology;2018